Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
June 6, 2016
| By Rachel Tompa / Fred Hutch News Service
Matthew Flood, a retired EMT from the Tacoma Fire Department, is one of 10 patients with metastatic melanoma treated with an experimental combination of immunotherapies between 2011 and 2013. In a study published today in the Journal of Clinical Oncology, the research team described the small clinical trial and how the patients have fared in the years following their treatment. Flood is now in complete remission five years after receiving the combo immunotherapy.
Aided by six Hutchinson Center 'doctor partners,' local grade schoolers explore possible cancer cures, visit campus
May 29, 2012
| By Colleen Steelquist
Budding sixth-grade scientists from Snohomish's Dutch Hill Elementary School recently spent the day on the Fred Hutchinson Cancer Research Center campus, the culmination of a yearlong exploratory partnership with Center researchers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.